Evaluation of Treatment Underreporting Using SEER-Medicare Data

使用 SEER-Medicare 数据评估治疗漏报

• 批准号: 8565098
• 负责人: ANTOINETTE STROUP
• 金额: $ 8.88万
• 依托单位: UNIVERSITY OF UTAH
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-30 至 2013-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8565098
• 关键词: Affect; Algorithms; Characteristics; Code; Data; Data Reporting; Data Set; Endometrial; Evaluation; Female breast; Hormones; Immunotherapy; Link; Malignant neoplasm of prostate; Measures; Medicare; Medicare claim; Modeling; Pattern; Process; Provider; Quality Control; Radiation; Registries; Reporting; Review Literature; Testing; Update; Work; base; cancer diagnosis; cancer site; chemotherapy; interest; oligodendroglioma; programs; tumor; working group

The primary objectives of this study are to (1) work closely with the SEER working groups and NCI to develop and implement algorithms that would be applied to SEER-Medicare data to identify oligodendrogliomas, female breast and endometrial, and prostate cancers diagnosed from 1992-2009 that received radiation, chemotherapy, hormone, and/or immunotherapy treatment; and, (2) define the process for incorporating additional information into the existing SEER treatment variables in SEER*DMS.

这项研究的主要目标是（1）与SEER工作组和NCI紧密合作，以开发和实施算法，这些算法将应用于SEER-MEDICARE数据，以识别少突endrogliomas，雌性乳房和子宫内膜和子宫内膜，以及从1992 - 2009年诊断出的，从1992- 2009年进行了诊断，接受了放射治疗，和/或免疫治疗，和/或免疫治疗，和/或免疫，或者接受治疗，或/或免疫治疗; （2）定义将其他信息纳入Seer*dms中现有的SEER治疗变量的过程。